Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）
Clinical trial NCT03735264 · UNKNOWN
Trial details
- NCT number
- NCT03735264
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2020-10-14
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.